Insider · CIK 0001688712

Bir Dawn Carter

Reports to the SEC for 4 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001688712

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-20	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+220K sh	—	—	220,000
2026-05-18	SOLENO THERAPEUTICS INCD Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2025-10-21	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+53K sh	—	—	53,000
2025-06-05	SOLENO THERAPEUTICS INCA Award	Director	AAward	+3,991 sh	—	—	16,991
2025-05-21	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2024-08-15	SOLENO THERAPEUTICS INCA Award	Director	AAward	+13K sh	—	—	13,000
2024-05-09	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+180K sh	—	—	180,000
2023-09-26	REATA PHARMACEUTICALS INCD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−33.8K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−17.3K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−17.3K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−34.5K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−71.3K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−63.7K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−70K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−24K sh	—	—	0
2023-08-16	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−398 sh	$168.33	−$67K	33,805
2023-08-15	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−807 sh	$169.04	−$136K	34,203
2023-07-28	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−40K sh	$164.54	−$6.58M	35,010
2023-07-28	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+40K sh	$22.57	+$903K	40,000
2023-07-28	REATA PHARMACEUTICALS INCClass B common stockC Conversion	Chief Commercial Officer	CConversion	−40K sh	—	—	0
2023-07-28	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−40K sh	—	—	0
2023-07-28	REATA PHARMACEUTICALS INCC Conversion	Chief Commercial Officer	CConversion	+40K sh	—	—	75,010
2023-07-06	REATA PHARMACEUTICALS INCA Award	Chief Commercial Officer	AAward	+4,125 sh	—	—	35,010
2023-05-31	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2023-05-16	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−417 sh	$80.95	−$33.8K	30,885
2023-05-15	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−894 sh	$85.09	−$76.1K	31,302
2023-03-13	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−9,317 sh	$86.77	−$808K	32,196
2023-03-07	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−36K sh	$85.08	−$3.07M	47,506
2023-03-07	REATA PHARMACEUTICALS INCClass B common stockC Conversion	Chief Commercial Officer	CConversion	−41.6K sh	—	—	0
2023-03-07	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+41.6K sh	$21.05	+$876K	41,630
2023-03-07	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−41.6K sh	—	—	0
2023-03-07	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−200 sh	$86.67	−$17.3K	41,513
2023-03-07	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−5,793 sh	$85.90	−$498K	41,713
2023-03-07	REATA PHARMACEUTICALS INCC Conversion	Chief Commercial Officer	CConversion	+41.6K sh	—	—	83,555
2023-03-06	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−40.1K sh	$89.30	−$3.58M	56,745
2023-03-06	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−14.8K sh	$90.26	−$1.34M	41,925
2023-03-06	REATA PHARMACEUTICALS INCC Conversion	Chief Commercial Officer	CConversion	+48.4K sh	—	—	96,879
2023-03-06	REATA PHARMACEUTICALS INCClass B common stockC Conversion	Chief Commercial Officer	CConversion	−48.4K sh	—	—	0
2023-03-06	REATA PHARMACEUTICALS INCClass B common stockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+48.4K sh	$21.05	+$1.02M	48,370
2023-03-06	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−48.4K sh	—	—	41,630
2023-03-03	REATA PHARMACEUTICALS INCS Sale	Chief Commercial Officer	SSale	−2,166 sh	$88.25	−$191K	48,509
2023-01-03	REATA PHARMACEUTICALS INCA Award	Chief Commercial Officer	AAward	+15.7K sh	—	—	50,675
2023-01-03	REATA PHARMACEUTICALS INCEmployee Stock Option (right-to-buy)A Award	Chief Commercial Officer	AAward	+63.7K sh	—	—	63,650
2022-05-10	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2022-01-03	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+70K sh	—	—	70,000
2022-01-03	REATA PHARMACEUTICALS INCA Award	Chief Commercial Officer	AAward	+35K sh	—	—	35,000
2021-05-11	GERNGERON CORP · Stock Option (right to buy)A Award	Director	AAward	+83K sh	—	—	83,000
2021-01-04	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+16.5K sh	—	—	16,500
2020-11-09	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−60K sh	—	—	90,000

Recent filings

Accepted (ET)
May 264
Bir Dawn Carter0001688712-26-000003
SEC(opens sec.gov)
May 184
Bir Dawn Carter0001688712-26-000001
SEC(opens sec.gov)
Oct 224
Bir Dawn Carter0001437749-25-031540
SEC(opens sec.gov)
Jun 94
Bir Dawn Carter0001415889-25-016355
SEC(opens sec.gov)
May 224
Bir Dawn Carter0000886744-25-000026
SEC(opens sec.gov)
Aug 164
Bir Dawn Carter0001415889-24-021503
SEC(opens sec.gov)
May 104
Bir Dawn Carter0000950170-24-057796
SEC(opens sec.gov)
Sep 264
Bir Dawn Carter0000899243-23-019542
SEC(opens sec.gov)
Aug 174
Bir Dawn Carter0001209191-23-046282
SEC(opens sec.gov)
Aug 14
Bir Dawn Carter0001209191-23-043986
SEC(opens sec.gov)

Companies

Address

C/O GERON CORPORATION 919 EAST HILLSDALE BOULEVARD, SUITE 250

FOSTER CITY, CA, 94404